Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy
暂无分享,去创建一个
R. Rubinshtein | B. Gersh | S. Ommen | J. Glockner | P. Araoz | R. Nishimura | P. Sorajja | Uma S. Valeti | A. Tajik | M. Ackerman | J. Bos
[1] B. Gersh,et al. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy , 2009, Heart.
[2] Warren J Manning,et al. Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy , 2008, Circulation. Heart failure.
[3] B. Gersh,et al. Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy , 2008, Circulation.
[4] S. Ommen,et al. Relationship between sex, shape, and substrate in hypertrophic cardiomyopathy. , 2008, American heart journal.
[5] W. Manning,et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.
[6] K. Takeda,et al. Correlation between late gadolinium enhancement and diastolic function in hypertrophic cardiomyopathy assessed by magnetic resonance imaging. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[7] W. Roberts,et al. Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status. , 2008, The American journal of cardiology.
[8] V. Fuster,et al. Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy , 2007, Nature Clinical Practice Cardiovascular Medicine.
[9] A. Tajik,et al. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. , 2007, European heart journal.
[10] B. Gersh,et al. Surgery Insight: septal myectomy for obstructive hypertrophic cardiomyopathy—the Mayo Clinic experience , 2007, Nature Clinical Practice Cardiovascular Medicine.
[11] L. Harris,et al. Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy , 2007, Heart.
[12] S. Ommen,et al. Hypertrophic cardiomyopathy, sudden death, and implantable cardiac defibrillators: how low the bar? , 2007, JAMA.
[13] M. Link,et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. , 2007, JAMA.
[14] P. Elliott,et al. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. , 2007, Journal of the American College of Cardiology.
[15] H. Sakahara,et al. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. , 2007, Journal of cardiac failure.
[16] N. Bellenger,et al. Ischaemic and non-ischaemic cardiomyopathies--cardiac MRI appearances with delayed enhancement. , 2007, Clinical radiology.
[17] A. Tajik,et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. , 2007, Journal of the American College of Cardiology.
[18] C. Kramer. The expanding prognostic role of late gadolinium enhanced cardiac magnetic resonance. , 2006, Journal of the American College of Cardiology.
[19] Dudley J Pennell,et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.
[20] W. Stevenson,et al. Characterization of the Peri-Infarct Zone by Contrast-Enhanced Cardiac Magnetic Resonance Imaging Is a Powerful Predictor of Post–Myocardial Infarction Mortality , 2006, Circulation.
[21] Roger B. Davis,et al. Impact of Unrecognized Myocardial Scar Detected by Cardiac Magnetic Resonance Imaging on Event-Free Survival in Patients Presenting With Signs or Symptoms of Coronary Artery Disease , 2006, Circulation.
[22] L. Monserrat,et al. Magnetic Resonance Imaging of Delayed Enhancement in Hypertrophic Cardiomyopathy: Relationship with Left Ventricular Perfusion and Contractile Function , 2006, Journal of computer assisted tomography.
[23] Michael J Ackerman,et al. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. , 2006, Mayo Clinic proceedings.
[24] C. Rochitte,et al. The emerging role of MRI in the diagnosis and management of cardiomyopathies , 2006, Current cardiology reports.
[25] R. Gibbons,et al. Prognostic utility of single-photon emission computed tomography in adult patients with hypertrophic cardiomyopathy. , 2006, American heart journal.
[26] M. Link,et al. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy. , 2005, The American journal of cardiology.
[27] C. Autore,et al. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. , 2005, Journal of the American College of Cardiology.
[28] P. Elliott,et al. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. , 2003, Journal of the American College of Cardiology.
[29] Heiko Mahrholdt,et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.
[30] B. Maron. Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.
[31] P. Elliott,et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.
[32] O. Simonetti,et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.
[33] W J McKenna,et al. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease , 2000, Heart.
[34] G Thiene,et al. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. , 2000, Human pathology.
[35] W. Mckenna,et al. The management of hypertrophic cardiomyopathy. , 1997, The New England journal of medicine.
[36] K. Bailey,et al. Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990. , 1995, Circulation.
[37] R. Bonow,et al. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). , 1987, The New England journal of medicine.
[38] W. McKenna,et al. The natural history of hypertrophic cardiomyopathy. , 1981, Cardiovascular clinics.
[39] O. Simonetti,et al. An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.
[40] W. Roberts,et al. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. , 2000, Journal of the American College of Cardiology.